Literature DB >> 18759919

Regulation of hematopoietic cell function by inhibitory immunoglobulin G receptors and their inositol lipid phosphatase effectors.

Carol T Cady1, Jeffrey S Rice, Vanessa L Ott, John C Cambier.   

Abstract

Numerous autoimmune and inflammatory disorders stem from the dysregulation of hematopoietic cell activation. The activity of inositol lipid and protein tyrosine phosphatases, and the receptors that recruit them, is critical for prevention of these disorders. Balanced signaling by inhibitory and activating receptors is now recognized to be an important factor in tuning cell function and inflammatory potential. In this review, we provide an overview of current knowledge of membrane proximal events in signaling by inhibitory/regulatory receptors focusing on structural and functional characteristics of receptors and their effectors Src homology 2 (SH2) domain-containing tyrosine phosphatase 1 and SH2 domain-containing inositol 5-phosphatase-1. We review use of new strategies to identify novel regulatory receptors and effectors. Finally, we discuss complementary actions of paired inhibitory and activating receptors, using Fc gammaRIIA and Fc gammaRIIB regulation human basophil activation as a prototype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18759919      PMCID: PMC2968700          DOI: 10.1111/j.1600-065X.2008.00663.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  109 in total

1.  A chemical genetic screen for direct v-Src substrates reveals ordered assembly of a retrograde signaling pathway.

Authors:  Kavita Shah; Kevan M Shokat
Journal:  Chem Biol       Date:  2002-01

2.  C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

Authors:  Nelli Shushakova; Julia Skokowa; Jurriaan Schulman; Ulrich Baumann; Jörg Zwirner; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Insulin receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt.

Authors:  M J Wick; L Q Dong; D Hu; P Langlais; F Liu
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

4.  IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma.

Authors:  M R Woolhiser; Y Okayama; A M Gilfillan; D D Metcalfe
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

5.  Regulated expression and inhibitory function of Fcgamma RIIb in human monocytic cells.

Authors:  Susheela Tridandapani; Kristina Siefker; Jean-Luc Teillaud; Jo Ellen Carter; Mark D Wewers; Clark L Anderson
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

6.  The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors.

Authors:  Koji Nakamura; Alexander Malykhin; K Mark Coggeshall
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

7.  Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.

Authors:  Vanessa L Ott; Idan Tamir; Masaru Niki; Pier Paolo Pandolfi; John C Cambier
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor.

Authors:  Aaron J Marshall; Allyson K Krahn; Kewei Ma; Vincent Duronio; Sen Hou
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression.

Authors:  Elizabeth U Rudge; Antony J Cutler; Nicholas R Pritchard; Kenneth G C Smith
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

10.  Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells.

Authors:  Alexis M Kalergis; Jeffrey V Ravetch
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  8 in total

1.  Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors.

Authors:  Lela Kardava; Susan Moir; Wei Wang; Jason Ho; Clarisa M Buckner; Jacqueline G Posada; Marie A O'Shea; Gregg Roby; Jenny Chen; Hae Won Sohn; Tae-Wook Chun; Susan K Pierce; Anthony S Fauci
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

Review 3.  Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.

Authors:  P Mark Hogarth; Geoffrey A Pietersz
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

4.  Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses.

Authors:  Halina M Trist; Peck Szee Tan; Bruce D Wines; Paul A Ramsland; Eva Orlowski; Janine Stubbs; Elizabeth E Gardiner; Geoffrey A Pietersz; Stephen J Kent; Ivan Stratov; Dennis R Burton; P Mark Hogarth
Journal:  J Immunol       Date:  2013-12-16       Impact factor: 5.422

Review 5.  Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.

Authors:  Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

6.  Antigen-induced oligomerization of the B cell receptor is an early target of Fc gamma RIIB inhibition.

Authors:  Wanli Liu; Hae Won Sohn; Pavel Tolar; Tobias Meckel; Susan K Pierce
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

7.  CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.542

8.  Testing the role of the FcγRIIB immunoreceptor tyrosine-based inhibitory motif in regulation of the B cell immune response.

Authors:  Raja Vuyyuru; Shixue Shen; Tim Manser
Journal:  Immun Inflamm Dis       Date:  2015-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.